Sarepta Therapeutics (SRPT) Current Assets (2010 - 2026)

Sarepta Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• In Q1 2026, Current Assets fell 5.04% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $2.3 billion (down 5.04% YoY), while the FY2025 annual figure was $2.5 billion, down 17.42% from the prior year.
• Current Assets was $2.3 billion for Q1 2026 at Sarepta Therapeutics, down from $2.5 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.1 billion in Q4 2024 to a low of $2.3 billion in Q1 2026.
• Historically, Current Assets has averaged $2.6 billion across 5 years, with a median of $2.5 billion in 2025.
• The sharpest annual moves came in 2022 and 2025: Current Assets climbed 20.16% in 2022, then slipped 17.42% in 2025.
• A 5-year view of Current Assets shows it stood at $2.6 billion in 2022, then grew by 0.84% to $2.6 billion in 2023, then rose by 19.16% to $3.1 billion in 2024, then slipped by 17.42% to $2.5 billion in 2025, then dropped by 8.99% to $2.3 billion in 2026.
• The last three Current Assets figures came in at $2.3 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.